Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Queensland becomes home to the first company in Australia offering whole genome analysis of cancer

Home All news & events News Queensland becomes home to the first company…

genomiQa is set to improve cancer diagnosis and treatment, using precision medicine to tailor treatment to patient’s cancer. genomiQa will offer hospitals, clinicians and companies high-quality analysis of data from whole genome sequencing.

Continue reading the article on the QIMR Berghofer Medical Research Institute website.

QIMR Berghofer Medical Research Institute is a key partner of Australian Genomics. QIMR Berghofer is focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of cancer, infectious diseases, mental health and complex disorders.

Its researchers are involved in a number of Australian Genomics projects, including a group focusing on genetic variant curation and sharing, under Australian Genomics’ Programs 1 and 2.